Monograph

The ERS Monograph is the quarterly book series from the ERS.

Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.

Community-Acquired Pneumonia

European Respiratory Society Monograph, Vol. 63. 2014

ISBN: 978-1-84984-049-1
DOI: 10.1183/1025448x.erm6314

Community-acquired pneumonia remains the leading cause of hospitalisation for infectious disease in Europe, and a major cause of morbidity and mortality. This issue of the European Respiratory Monograph brings together leading experts in pulmonology, infectious diseases and critical care from around the world to present the most recent advances in the management of community-acquired pneumonia. It provides a comprehensive overview of the disease, including chapters on microbiology, pathophysiology, antibiotic therapy and prevention, along with hot topics such as viral pneumonias and pneumonia associated with inhaled corticosteroids.

CME test: ERS Monograph 63: Community-Acquired Pneumonia
Preface Eur Respir Monogr 2014; 63: v
Guest Editors Eur Respir Monogr 2014; 63: vii-viii
Introduction James D. Chalmers, Mathias W. Pletz, Stefano Aliberti Eur Respir Monogr 2014; 63: ix-9
Epidemiology of CAP in Europe Anika Singanayagam, James D. Chalmers, Tobias Welte Eur Respir Monogr 2014; 63: 1-12
The pneumonia triad Santiago Ewig Eur Respir Monogr 2014; 63: 13-24
Microbiology of bacterial CAP using traditional and molecular techniques Mayli Lung, Jordi Rello Eur Respir Monogr 2014; 63: 25-41
The pathophysiology of pneumococcal pneumonia Daniel G. Wootton, Stephen J. Aston, Stephen B. Gordon Eur Respir Monogr 2014; 63: 42-63
Pneumonia due to Mycoplasma, Chlamydophila and Legionella Francesco Blasi, Paolo Tarsia, Marco Mantero Eur Respir Monogr 2014; 63: 64-73
The role of viruses in CAP Gernot G.U. Rohde Eur Respir Monogr 2014; 63: 74-87
Severity assessment tools in CAP Helena Sintes, Oriol Sibila, Grant W. Waterer, James D. Chalmers Eur Respir Monogr 2014; 63: 88-104
CAP phenotypes Benjamin Klapdor, Santiago Ewig, Antoni Torres Eur Respir Monogr 2014; 63: 105-116
Lower respiratory tract infections and adult CAP in primary care Matt P. Wise, Christopher C. Butler Eur Respir Monogr 2014; 63: 117-129
CAP in children Susanna Esposito, Maria Francesca Patria, Claudia Tagliabue, Benedetta Longhi, Simone Sferrazza Papa, Nicola Principi Eur Respir Monogr 2014; 63: 130-139
Empirical antibiotic management of adult CAP Mark Woodhead, Muhammad Noor Eur Respir Monogr 2014; 63: 140-154
Antibiotic choice, route and duration: minimising the harm associated with antibiotics Rosario Menendez, Beatriz Montull, Raul Mendez Eur Respir Monogr 2014; 63: 155-167
Acute respiratory failure due to CAP Miquel Ferrer Eur Respir Monogr 2014; 63: 168-183
Early recognition and treatment of severe sepsis and septic shock in CAP Anja Kathrin Jaehne, Namita Jayaprakash, Gina Hurst, Steven Moore, Michael F. Harrison, Emanuel P. Rivers Eur Respir Monogr 2014; 63: 184-204
Early outcomes in CAP: clinical stability, clinical failure and nonresolving pneumonia Stefano Aliberti, Paola Faverio Eur Respir Monogr 2014; 63: 205-218
Non-antibiotic therapies for CAP Paola Faverio, Marcos I. Restrepo Eur Respir Monogr 2014; 63: 219-233
Inhaled corticosteroids as a cause of CAP Peter M.A. Calverley Eur Respir Monogr 2014; 63: 234-242
Macrolides as anti-inflammatory agents in CAP Waleed Salih, Philip M. Short, Stuart Schembri Eur Respir Monogr 2014; 63: 243-255
Cardiovascular complications and comorbidities in CAP Stefan Krüger, Dirk Frechen Eur Respir Monogr 2014; 63: 256-254
Pneumococcal and influenza vaccination Mathias W. Pletz, Tobias Welte Eur Respir Monogr 2014; 63: 266-284